Gxp Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.50 Cr
- Revenue Growth %
- Profit Growth 84.19%
- Ebitda 83.13%
- Net Worth -9.52%
- Total Assets -24.05%
About Gxp Pharmaceuticals
Gxp Pharmaceuticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2011 and has a history of 13 years and three months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹9.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anand Jain, Sanjiv Puri, and Aryan Puri serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191PN2011PTC156428
-
Company No.
156428
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 2011
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Gxp Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiv Puri
|
Managing Director | 15-Oct-2011 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Jain
|
Director | 01-Mar-2021 | Current |
|
Aryan Puri
|
Director | 29-Dec-2020 | Current |
Financial Performance of Gxp Pharmaceuticals.
Gxp Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 84.19% increase in profit. The company's net worth dipped by a decrease of 9.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gxp Pharmaceuticals?
In 2023, Gxp Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Zinpro Animal Nutrition India Private LimitedAnand Jain is a mutual person
-
Eviview India Private LimitedAnand Jain is a mutual person
-
Unidays Private LimitedAnand Jain is a mutual person
Charges (Loans)
₹0
₹95.00 M
Charges Breakdown by Lending Institutions
- Gvk Biosciences Private Limited : 9.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2014 | Gvk Biosciences Private Limited | ₹9.50 Cr | Satisfied |
How Many Employees Work at Gxp Pharmaceuticals?
Gxp Pharmaceuticals has a workforce of 14 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gxp Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gxp Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
